Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by V-H-gene mutational status
Mockridge, C. Ian, Potter, Kathleen N., Wheatley, Isla, Neville, Louise A., Packham, Graham and Stevenson, Freda K. (2007) Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by V-H-gene mutational status. Blood, 109, (10), 4424-4431. (doi:10.1182/blood-2006-11-056648).
Download
Full text not available from this repository.
Description/Abstract
The 2 subsets of chronic lymphocytic leukemia (CLL), of worse or better prognosis, likely derive from pre-GC unmutated B cells, or post-GC mutated B cells, respectively. Different clinical behavior could relate to the ability of tumor cells to respond to surface (slg)-mediated signals. Unmutated cases (U-CLL) have an increased ability to phosphorylate p72(Syk) in response to slgM ligation compared to mutated cases (M-CLL). We now confirm and further investigate this differential signaling in a large cohort by [Ca2+], mobilization. Cases responding to slgM ligation express higher levels of CD38, ZAP-70, and slgM. However, CD38 does not influence signaling in vitro or associate with response in bimodal CD38-expressing cases. Similarly, ZAP-70 expression is not required for response in either U-CLL or M-CLL. Strikingly, partially or completely anergized slgM responses from each subset can recover both slgM expression and signal capacity spontaneously in vitro or following capping/enclocytosis. This provides direct evidence for engagement of putative antigen in vivo. Signaling via slgD differs markedly being almost universally positive in both U-CLL and M-CLL, with no association with CD38 or ZAP-70 expression. Downstream signaling pathways, therefore, appear intact in CLL, locating anergy to slgM, mainly in M-CLL. Integration of differential isotype-specific effects mediated by (auto)antigen may determine tumor behavior.
| Item Type: | Article |
|---|---|
| ISSNs: | 0006-4971 (print) |
| Related URLs: | |
| Keywords: | pathway, immunoglobulin, b cell, tyrosine kinase, tumor-cells, cell, surface, zap-70 expression, pathways, cohort, chronic lymphocytic-leukemia, activation, time, responses, expression, b-cell-receptor, prognosis, leukemia, antigen, in-vitro, lymphocytic-leukemia, cross-linking, antigen receptor, cd38 expression, tumor, cll, cd38, cells, b-cells, vivo, in-vivo, zap-70, surface igm |
| Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) Q Science > QH Natural history > QH426 Genetics |
| Divisions: | University Structure - Pre August 2011 > School of Medicine > Cancer Sciences |
| Item ID: | 62853 |
| Date Deposited: | 12 Nov 2008 |
| Last Modified: | 23 Jul 2012 12:02 |
| Contributors: | Mockridge, C. Ian (Author) Potter, Kathleen N. (Author) Wheatley, Isla (Author) Neville, Louise A. (Author) Packham, Graham (Author) Stevenson, Freda K. (Author) |
| Date: | 15 May 2007 |
| Status: | Published |
| URI: | http://eprints.soton.ac.uk/id/eprint/62853 |
Actions (login required)
 |
View Item |
